Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis

This post hoc analysis of ACQUIRE (NCT00559585) explored the effect of baseline body mass index (BMI) on the pharmacokinetics of and clinical response to subcutaneous (SC) or intravenous (IV) abatacept in patients with rheumatoid arthritis (RA). ACQUIRE was a phase 3b, 6-month, double-blind, double-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Rheumatol
Main Authors: D’Agostino, Maria-Antonietta, Alten, Rieke, Mysler, Eduardo, Le Bars, Manuela, Ye, June, Murthy, Bindu, Heitzmann, Julia, Vadanici, Radu, Ferraccioli, Gianfranco
Formato: Artigo
Idioma:Inglês
Publicado em: Springer London 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5681604/
https://ncbi.nlm.nih.gov/pubmed/28822046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-017-3788-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados